Lupin shares slide 4% amid profit booking post March quarter results

During the past six trading days, Lupin outperformed the market and surged 15 per cent as compared to a per cent rise in the S&P BSE Sensex till Wednesday

Shares of Lupin were down 4 per cent to Rs 1,165.95 on the BSE in the intra-day trade on Friday on profit booking after the company's consolidated sales declined 0.8 per cent year on year (YoY) to Rs 3,759 crore for the quarter ended March 31, 2021 (Q4FY21), led by a YoY decline in US and in API (active pharmaceutical ingredient) sales. The pharmaceutical's company had posted sales of Rs 3,791 crore in the corresponding period of FY20.

During the past six trading days, Lupin outperformed the market and surged 15 per cent, as compared to a per cent